Financials BIO-UV Group

Equities

Market Closed - Euronext Paris Other stock markets 11:35:04 2024-06-07 am EDT			5-day change	1st Jan Change
2.25 ^EUR	-0.44%		+0.22%	-7.98%

Feb. 20	Bio-UV: partnership with U.S.-based Pinnacle Ozone	CF
Jan. 25	Bio-UV: return to growth forecast for 2024	CF

Fiscal Period: December	2018	2019	2020	2021	2022	2023	2024
Capitalization ¹	24.92	27.43	69.53	52.95	47.1	22.79	22.79
Enterprise Value (EV) ¹	25.88	38.77	70.62	80.55	72	24.76	39.69
P/E ratio	530 x	-61.4 x	85.1 x	70.8 x	19.6 x	5.56 x	3.63 x
Yield	-	-	-	0.95%	1.29%	2.22%	2.22%
Capitalization / Revenue	2.01 x	1.37 x	2.16 x	1.58 x	0.91 x	0.57 x	0.33 x
EV / Revenue	2.08 x	1.94 x	2.19 x	2.4 x	1.4 x	0.57 x	0.57 x
EV / EBITDA	30.1 x	29.5 x	21.4 x	20.7 x	10.3 x	4.5 x	3.2 x
EV / FCF	-6.7 x	-15.5 x	-24.4 x	134 x	-	10.3 x	6.61 x
FCF Yield	-14.9%	-6.43%	-4.1%	0.74%	-	9.67%	15.1%
Price to Book	1.49 x	-	-	-	-	0.6 x	0.52 x
Nbr of stocks (in thousands)	7,838	7,838	10,347	10,105	10,097	10,127	10,127
Reference price ²	3.180	3.500	6.720	5.240	4.665	2.250	2.250
Announcement Date	4/11/19	4/29/20	4/7/21	4/6/22	4/3/23	4/3/24	-

¹EUR in Million²EUR

Estimates

Fiscal Period: December	2018	2019	2020	2021	2022	2023	2024
Net sales ¹	12.42	19.98	32.2	33.5	51.5	43.1	69.3
EBITDA ¹	0.859	1.312	3.3	3.9	7	5.5	12.4
EBIT ¹	0.0829	-0.3419	1.4	1	4.1	2.3	9.7
Operating Margin	0.67%	-1.71%	4.35%	2.99%	7.96%	5.34%	14%
Earnings before Tax (EBT) ¹	-0.197	-0.777	0.5535	0.6313	-	3.342	-
Net income ¹	0.046	-0.4481	0.6	0.7	2.4	0.1	6.6
Net margin	0.37%	-2.24%	1.86%	2.09%	4.66%	0.23%	9.52%
EPS ²	0.006000	-0.0570	0.0790	0.0740	0.2377	0.4050	0.6200
Free Cash Flow ¹	-3.864	-2.493	-2.894	0.6	-	4.424	6
FCF margin	-31.13%	-12.48%	-8.99%	1.79%	-	8.22%	8.66%
FCF Conversion (EBITDA)	-	-	-	15.38%	-	50.44%	48.39%
FCF Conversion (Net income)	-	-	-	85.71%	-	102.6%	90.91%
Dividend per Share ²	-	-	-	0.0500	0.0600	0.0500	0.0500
Announcement Date	4/11/19	4/29/20	4/7/21	4/6/22	4/3/23	4/3/24	-

¹EUR in Million²EUR

Estimates

Fiscal Period: December	2018	2019	2020	2021	2022	2023	2024
Net Debt ¹	0.96	11.3	1.09	27.6	24.9	22.9	16.9
Net Cash position ¹	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	1.115 x	8.638 x	0.329 x	7.077 x	3.557 x	2.617 x	1.363 x
Free Cash Flow ¹	-3.86	-2.49	-2.89	0.6	-	4.42	6
ROE (net income / shareholders' equity)	0.41%	-1.46%	2.5%	2.27%	7.61%	14.4%	14.3%
ROA (Net income/ Total Assets)	-	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-	-
Book Value Per Share ²	2.140	-	-	-	-	3.740	4.310
Cash Flow per Share ²	0.0600	0.1000	0.3200	0.3200	0.2700	0.8100	0.9000
Capex ¹	1.97	1.91	3.02	2.7	-	2	2
Capex / Sales	15.87%	9.56%	9.37%	8.06%	-	3.72%	2.89%
Announcement Date	4/11/19	4/29/20	4/7/21	4/6/22	4/3/23	4/3/24	-

¹EUR in Million²EUR

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.25 EUR

Average target price

6.2 EUR

Spread / Average Target

+175.56%